Tech Company Financing Transactions
Abdera Therapeutics Funding Round
Abdera Therapeutics, based in Vancouver, British Columbia, scored $142 million from Amplitude Ventures, venBio Partners and Versant Ventures.
Transaction Overview
Company Name
Announced On
4/20/2023
Transaction Type
Venture Equity
Amount
$142,000,000
Round
Undisclosed
Proceeds Purpose
This funding to advance a fleet of radiopharmaceuticals, with an application to begin human trials slated to go before regulators sometime next year.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1770 West 7th Avenue 5th Floor
Vancouver, British Columbia, V6J 4Z9
CA
Vancouver, British Columbia, V6J 4Z9
CA
Phone
Undisclosed
Website
Email Address
Overview
Abdera Therapeutics Inc. is a precision oncology company developing next-generation targeted radiation therapies - one of the most cutting-edge and highly promising areas of drug development. The company is built on a proprietary modular technology platform optimized for the delivery of radioisotopes to selectively destroy tumor cells while sparing healthy cells. Abdera is using this platform to enable the rapid development of a broad range of safe and efficacious therapies serving cancer patients with limited treatment options.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lori Williams
Chief Financial Officer
Jennifer McNealey
Chief Technical Officer
Kawa Chiu
Co-Founder
Michael Abrams
Browse more venture capital transactions:
Prev: 4/20/2023: Complai venture capital transaction
Next: 4/20/2023: Chargel venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC transactions on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs